Company / Free Cash Flow
PROCEPT BioRobotics Corp Free Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$58.3M
FY2025
5-year range
-$133.2M / -$57.9M
FY2021-FY2025
Trend
+43.7%
vs FY2024
Sector context
#131 of 147
Health Care
What the data says
PROCEPT BioRobotics Corp's free cash flow of -$58M is lower than 89% of companies in the Health Care sector (FY2025). Improved from -$133M to -$58M over the past 2 years.
Based on SEC 10-K filings.
-$58M in FY2025.
Improved from -$133M to -$58M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 147This company -$58.3M Sector average $762.7M
▼
-107.6% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 43.7% year-over-year.
- Ranks #131 out of 147 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$58.3M | +43.7% |
| FY2024 | -$103.6M | +22.2% |
| FY2023 | -$133.2M | -60.4% |
| FY2022 | -$83.0M | -43.3% |
| FY2021 | -$57.9M | -19.2% |
| FY2020 | -$48.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026